# 无针血液采集设备市场

> 无针采血装置市场研究报告，按应用（血液检测、血糖检测、免疫检测、基因检测）、按技术（振动技术、喷射注射技术、电穿孔技术）、按最终用途（医院、诊所、居家护理、实验室）、按分销渠道（在线零售、药店、直接销售、医疗分销商）以及按地区（北美、欧洲、南美、亚太、中东和非洲） - 预测至2035年

- **Forecast Period:** 2025 - 2035
- **CAGR:** 9.02%
- **2024:** $ 2.51 Billion
- **2025:** $ 2.74 Billion
- **2035:** $ 6.5 Billion
- **Key Players:** GlucoRx (GB), VivaLNK (US), Becton Dickinson (US), HemoCue (SE), Nemaura Medical (GB), Tasso Inc. (US), Syris Scientific (US), Aterica (CA)

**Report ID:** MRFR/HC/36925-HCR · **Pages:** 100 · **Author:** Nidhi Mandole & Rahul Gotadki · **Last Updated:** August 24, 2026

**URL:** https://www.marketresearchfuture.com/reports/needle-free-blood-drawing-device-market-38906

---

## Market Summary

## **Needle-Free Blood Drawing Device Market Overview**

As per MRFR analysis, the Needle-Free Blood Drawing Device Market Size was estimated at 2.51 (USD Billion) in 2024. The Needle-Free Blood Drawing Device Market Industry is expected to grow from 2.74 (USD Billion) in 2025 to 5.96 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 9.02% during the forecast period (2025 - 2034).

**Key Needle-Free Blood Drawing Device Market Trends Highlighted**

The Needle-Free Blood Drawing Device Market is experi immense growth as more people seek safer options in blood collection methods. Chronic disease management and monitoring requiring regular bloodwork, among other factors, are some of the key market demand drivers. Furthermore, rising concern about the threat of infections or injuries from needle sticks has aroused interest in these needle-free technologies, which many practitioners now favor. There is a great deal of opportunity in the market, especially in developing regions where healthcare infrastructure is advancing rapidly.

More resources should be put into R&D to allow the invention of new products that will innovate these devices and make them efficient and affordable.

The practice of home care is becoming more popular and gives manufacturers an opportunity to reach out to customers. In addition, incorporating advanced features, such as digital health or connectivity, can improve satisfaction and expand the electromedical market related to needle-free devices. The last few years have seen a trend toward wider use of these devices in areas such as hospitals, diagnostic laboratories and home care. The increasing use of telemedicine and remote patient monitoring has increased the demand for simple, painless approaches to blood collection.

Companies seek to grow their presence in larger markets by forming partnerships and collaboratives as a means of enhancing their skills.The emphasis on sustainability and eco-friendly practices is also influencing product designs, prompting manufacturers to explore biodegradable materials and reusable systems. As the landscape evolves, the market is poised for continued transformation, responding dynamically to the changing needs of patients and healthcare providers alike.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**Needle-Free Blood Drawing Device Market Drivers**

Increasing Demand for Minimally Invasive Procedures

The Needle-Free Blood Drawing Device Market Industry is experiencing significant growth driven by the rising demand for minimally invasive medical procedures. As healthcare professionals and patients increasingly prioritize comfort and reduce the risk associated with traditional blood drawing methods, there has been a notable shift towards technologies that facilitate pain-free blood collection.

This change reflects a broader trend in the healthcare sector that seeks to minimize patient discomfort and anxiety associated with medical procedures.The advancement of needle-free blood drawing devices caters to this need by offering an innovative solution that not only enhances patient comfort but also improves the overall experience of healthcare interventions. These devices are designed using advanced technology that ensures precision and reliability while providing a pain-free alternative to the traditional needle-based methods.

With the increasing focus on patient-centered care, healthcare providers are more likely to adopt these devices as a standard procedure, which will further drive market growth in the coming years.Additionally, as hospitals and clinics strive to optimize their operational efficiencies, the incorporation of such advanced medical devices aligns well with their goals of improving patient throughput and satisfaction rates. The Needle-Free Blood Drawing Device Market Industry is thus positioned to expand significantly as both the medical community and patients continue to advocate for less invasive, safer, and more comfortable healthcare solutions.

Technological Advancements in Healthcare

Technological advancements play a crucial role in driving the growth of the Needle-Free Blood Drawing Device Market Industry. Continuous innovations and improvements in medical technology have led to the development of more efficient, accurate, and user-friendly needle-free blood drawing devices. As manufacturers invest in research and development, they create products that not only improve the ease of blood collection but also enhance safety features, reduce the risk of infection, and increase the reliability of blood tests.These advancements attract both healthcare providers and patients, propelling the market towards further expansion.

Rising Incidence of Chronic Diseases

The prevalence of chronic diseases such as diabetes and cardiovascular disorders is on the rise worldwide, increasing the demand for regular blood testing and monitoring. This trend significantly contributes to the growth of the Needle-Free Blood Drawing Device Market Industry, as patients with chronic conditions require frequent blood draws for diagnostic and monitoring purposes.

Needle-free devices provide a more comfortable experience for these patients, encouraging compliance with testing protocols and making them an attractive option for both individuals and healthcare providers.As the healthcare landscape continues to evolve towards proactive and preventive healthcare measures, the demand for needle-free blood drawing solutions is expected to grow.

**Needle-Free Blood Drawing Device Market Segment Insights:**

**Needle-Free Blood Drawing Device Market Application Insights  **

The Needle-Free Blood Drawing Device Market is experiencing notable growth, primarily driven by advancements in technology and heightened awareness of patient comfort and safety. With the overall market valued at 2.12 USD Billion in 2023, the Application segment showcases compelling dynamics that offer crucial insights into market trends.

Among the various applications, the Blood Tests category stands out, holding a significant share valued at 0.75 USD Billion this year, and is projected to reach 1.65 USD Billion by 2032, making it a dominant player in the Needle-Free Blood Drawing Device Market segmentation. This is primarily because of the escalating demand for routine health check-ups and diagnostic procedures aimed at early disease detection and management.

In addition, the Glucose Testing segment is also notable, valued at 0.45 USD Billion in 2023 and expected to see growth to 1.0 USD Billion by 2032. This segment has gained traction due to the increasing prevalence of diabetes and the need for regular blood glucose monitoring, significantly impacting the Needle-Free Blood Drawing Device Market revenue.

The Immunological Testing market, valued at 0.33 USD Billion in 2023, is also expected to grow to 0.7 USD Billion in 2032, driven by a rising awareness of immune system disorders and infectious diseases, highlighting its significance within the industry as it facilitates timely detection and monitoring.

Lastly, the Genetic Testing application is noteworthy, starting with a market value of 0.59 USD Billion in 2023 and projected to grow to 1.25 USD Billion by 2032. This segment's growth is attributed to the increasing demand for personalized medicine and genetic profiling, which plays a critical role in tailoring healthcare solutions for individuals. The diversity present in the Application segment of the Needle-Free Blood Drawing Device Market data illustrates a multi-faceted landscape where specific applications address unique healthcare needs.

Collectively, these applications showcase a robust and evolving market that reflects broader trends in healthcare, emphasizing patient-centric approaches and the shift towards less invasive medical procedures, thereby presenting ample opportunities for industry growth.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**Needle-Free Blood Drawing Device Market Technology Insights  **

The Needle-Free Blood Drawing Device Market is poised for significant growth, with a projected market value of 2.12 USD Billion in 2023. This market is primarily categorized by technology, including Vibrational Technology, Jet Injection Technology, and Electroporation Technology. Vibrational Technology is notable for its ability to utilize vibrations to facilitate blood collection, which has garnered attention for improving patient comfort while reducing anxiety typically associated with traditional blood draws.

Jet Injection Technology employs a high-velocity jet of fluid, making it an efficient choice for blood collection without needles, thus minimizing the risk of needle-associated injuries.Electroporation Technology enables permeation of the cell membrane, allowing for blood collection via painless micro-electroporation, which is essential in enhancing patient compliance. The anticipated market growth, driven by factors such as rising demand for painless medical procedures and technological advancements, provides a promising outlook for these segments. However, challenges remain, including regulatory hurdles and the need for clinical validation to ensure safety and efficacy.

Overall, the Needle-Free Blood Drawing Device Market statistics reveal a robust trend towards innovative blood collection methods that are both patient-friendly and efficient.

**Needle-Free Blood Drawing Device Market End-Use Insights  **

The Needle-Free Blood Drawing Device Market is experiencing notable advancements, especially within the End Use segment. As of 2023, the market was valued at 2.12 USD Billion, highlighting its growing significance in healthcare. Hospitals play a crucial role in the adoption of these devices, often leading in the implementation of innovative technologies to enhance patient comfort and safety. Clinics are also significant in the shift toward needle-free solutions, focusing on improving patient experience while drawing blood for diagnostics.

Home Care Settings represent an increasing trend, enabling patients to conduct blood draws independently, which is essential for chronic condition management.Laboratories benefit from the efficiency of needle-free devices, reducing the risk of contamination and errors associated with traditional blood drawing methods. The synergistic growth among these various End-use applications contributes significantly to the overall Needle-Free Blood Drawing Device Market revenue, shaping a robust landscape amid evolving healthcare needs.

The presence of strong growth drivers, such as rising demand for patient-friendly procedures and technological advancements, presents exciting opportunities within the industry while also facing challenges in terms of regulatory approvals and market penetration.

**Needle-Free Blood Drawing Device Market Distribution Channel Insights  **

The Needle-Free Blood Drawing Device Market is experiencing substantial growth within the distribution channel segment, contributing to an overall market valuation of 2.12 billion USD in 2023, with expectations to reach 4.6 billion USD by 2032. Diverse channels, including Online Retail, Pharmacies, Direct Sales, and Healthcare Distributors, characterize the market. Online retail has gained traction as a convenient platform for consumers, enhancing accessibility to these devices. Pharmacies play a critical role in community-based healthcare, providing readily available solutions to patients.Direct Sales are essential for establishing personal connections with healthcare providers, enabling tailored offerings and dedicated support.

Healthcare Distributors dominate as they streamline product access to various healthcare settings, making them a significant player within the market. As the Needle-Free Blood Drawing Device Market industry evolves, factors such as increased demand for minimally invasive procedures and rising awareness of safety in blood collection processes are driving market growth. Nevertheless, challenges related to regulatory compliance and potential market competition present ongoing hurdles.The overall market statistics support a promising forecast for distribution channels, reflecting the expanding reach and utilization of needle-free blood-drawing technologies.

**Needle-Free Blood Drawing Device Market Regional Insights  **

The Needle-Free Blood Drawing Device Market is experiencing notable growth across various regions, with a valuation of 2.12 USD Billion in 2023. North America leads the market, valued at 0.95 USD Billion in 2023, and is expected to reach 2.05 USD Billion by 2032, reflecting its major role in innovation and healthcare infrastructure.

Europe follows, holding a valuation of 0.75 USD Billion in 2023, predicted to grow to 1.55 USD Billion by 2032, largely driven by advancements in medical technology and rising demand for minimally invasive procedures.The APAC region shows potential for growth, starting at 0.3 USD Billion in 2023 and expected to rise to 0.8 USD Billion by 2032, with increasing healthcare investments and a rising patient population.

South America and MEA have smaller market shares, valued at 0.05 USD Billion and 0.07 USD Billion in 2023, respectively, but are anticipated to grow to 0.15 USD Billion and 0.25 USD Billion by 2032, highlighting opportunities for expansion as healthcare access improves in these regions. Overall, the diverse Needle-Free Blood Drawing Device Market segmentation presents various growth drivers, challenges, and opportunities, underscoring its potential in the healthcare industry.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**Needle-Free Blood Drawing Device Market Key Players and Competitive Insights:**

The Needle-Free Blood Drawing Device Market is evolving rapidly, driven by an increasing demand for safer and more efficient methods of blood collection. This market has garnered considerable attention due to the potential for enhancing patient comfort, reducing the risk of needle-stick injuries, and minimizing biohazard waste. Competitive dynamics within this segment highlight various players innovating and expanding their product portfolios, emphasizing technological advancements to cater to diverse medical needs.

As healthcare systems globally shift towards more patient-centric solutions, the competitive landscape is defined by a blend of established manufacturers and emerging startups seeking to carve out their niche in needle-free technologies. Alongside innovations, market participants are focusing on partnerships and collaborations that aim to bolster their market reach and enhance their technological capabilities, ultimately shaping the future landscape of blood collection processes.Fresenius Kabi has positioned itself effectively within the Needle-Free Blood Drawing Device Market with a strong emphasis on high-quality medical solutions.

Exhibiting extensive expertise in the healthcare and pharmaceutical sectors, the company has built a reputation for innovation and reliability. The strengths of Fresenius Kabi in this niche market include its commitment to research and development, enabling the company to deliver advanced needle-free blood drawing products that meet regulatory standards and fulfill ethical supply chain requirements. In addition, Fresenius Kabi's vast distribution network ensures broad accessibility to its innovative devices, further reinforcing its competitive advantage.

By focusing on patient safety and comfort, the company aligns itself with the shifting preferences of healthcare providers and patients alike, thus solidifying its position in this growing market.NantBio, on the other hand, presents a compelling overview of its operations within the Needle-Free Blood Drawing Device Market, marked by a strong focus on product efficacy and user experience. With an innovative approach to blood collection technologies, NantBio has developed solutions that combine advanced science with practical application. The company leverages sophisticated research methodologies to engineer devices that minimize discomfort during blood draws, ultimately enhancing patient satisfaction.

NantBio has also cultivated a strategic alliance with various healthcare systems, promoting the adoption of its needle-free solutions and aligning with the growing trend towards minimizing invasive procedures in medical settings. Its agility in responding to market needs and demands allows NantBio to swiftly adapt and innovate, thereby enhancing its presence in a highly competitive industry marked by rapid technological advancements and evolving consumer preferences.

**Key Companies in the Needle-Free Blood Drawing Device Market Include:**

**Needle-Free Blood Drawing Device Market Industry Developments**

The Needle-Free Blood Drawing Device Market has recently experienced significant developments, particularly with advancements in technology and increased consumer demand for painless procedures. Several companies, such as Fresenius Kabi, PharmaJet, and Becton Dickinson, have introduced innovative devices that enhance user experience and minimize discomfort. The market is seeing a surge in investments, with firms like Zyga Technology and Vita Needle making strides in R&D to launch more efficient needle-free systems. Current trends indicate a shift towards home-based healthcare solutions, aligning with rising patient preferences for convenience and safety.

 Additionally, key mergers and acquisitions are shaping the landscape, with companies like Terumo and Valeritas exploring strategic partnerships to expand their product offerings. The valuation of these companies is increasing, reflecting a growing market potential driven by technological advancements and a rising focus on patient-centric solutions. As the sector evolves, firms such as Bloodstasis and Microneedle Technologies are also pursuing collaborations to enhance their market reach and customer engagement. This dynamically changing environment underscores the broader transformation within the Needle-Free Blood Drawing Device Market.

**Needle-Free Blood Drawing Device Market Segmentation Insights**

## Market Drivers

### 技术创新

无针采血装置市场正在经历技术创新的激增，这些创新提高了血液采集的效率和安全性。最近在微流体技术和激光技术方面的进展导致了无须针头即可抽取血液的装置的开发。这些创新不仅减少了传统抽血所带来的疼痛，还最小化了针刺伤的风险。因此，医疗服务提供者越来越多地采用这些装置，预计在未来五年内将以约15%的复合年增长率增长。这一趋势表明无针解决方案具有强大的市场潜力，推动因素是对更安全和更以患者为中心的血液采集方法的需求。

### 支持性的监管环境

无针采血装置市场受到有利的监管环境的支持，该环境鼓励创新和新技术的采用。监管机构越来越认识到无针装置的好处，从而简化了新产品的审批流程。这一支持性框架不仅促进了创新解决方案进入市场，还增强了医疗服务提供者对这些装置安全性和有效性的信心。随着法规的发展，促进更安全的采血方法，无针采血装置市场有望实现显著增长，反映出行业对改善患者护理的承诺。

### 加强对患者安全的关注

无针采血装置市场受到医疗环境中对患者安全关注加剧的显著影响。与使用针头相关的感染和并发症风险促使医疗服务提供者寻求更安全的替代方案。无针装置降低了针刺伤的可能性，这对医疗专业人员来说是一个主要关注点。监管机构也在倡导更安全的血液采集方法，这进一步支持了无针技术的采用。随着医院和诊所实施更严格的安全协议，对无针采血装置的需求预计将上升，表明市场增长轨迹强劲。

### 对微创手术需求的上升

无针采血装置市场正见证对微创医疗程序日益增长的需求。患者因对疼痛和不适的担忧，越来越寻求传统采血的替代方案。无针装置提供了一种符合这一需求的解决方案，为患者提供了更少创伤的体验。随着医疗系统优先考虑患者的舒适度和满意度，这些装置的市场预计将扩大。此外，慢性疾病的日益普遍需要定期进行血液检测，进一步推动了对创新采血方法的需求。这种向微创技术的转变可能会推动无针采血装置市场的增长。

### 日益增长的意识和接受度

无针采血装置市场正在受益于医疗专业人员和患者之间日益增强的意识和接受度。教育倡议和营销活动有效地传达了无针采血方法的优势。随着越来越多的医疗提供者认识到这些设备的好处，包括减少疼痛和提高患者依从性，采用率可能会增加。此外，患者对他们的选择变得更加了解，导致对较少侵入性程序的偏好。这种日益增长的接受度预计将推动市场增长，因为越来越多的医疗机构将无针解决方案整合到他们的实践中。

## Future Outlook

无针采血装置市场预计将在2024年至2035年间以9.02%的年均增长率增长，推动因素包括技术进步、患者舒适度提高以及对微创手术需求的增加。

**New opportunities:**

- 开发便携式无针设备以适应家庭医疗环境。

到2035年，市场预计将实现显著增长，成为创新医疗解决方案的领导者。

## Segment Insights

### 按应用：血液检测（最大）与血糖测试（增长最快）

在无针采血设备市场中，应用细分市场主要由血液检测主导，后者占据了最大的市场份额。该细分市场显著受益于患者对常规血液分析日益增长的需求，这一需求受到医疗技术进步和医疗支出增加的推动。在血液检测之后，血糖检测作为一个重要参与者，因糖尿病的日益普遍和患者对更便捷检测方法的需求而获得了关注。

应用细分市场的增长趋势以无针技术在血糖检测中的快速采用为特征，后者被视为增长最快的领域。对血液采样过程中疼痛管理的认识提高以及以患者为中心的医疗方法是推动这一趋势的重要因素。同时，血液检测也在不断发展，技术创新提高了准确性并缩短了周转时间，巩固了其在市场中的主导地位。

应用：血液检测（主导）与葡萄糖检测（新兴）

血液检测应用以其成熟的市场存在和在临床环境中的广泛使用为特征。作为一个主导力量，该细分市场受益于强大的医疗法规框架和对准确患者诊断的必要性。相比之下，葡萄糖检测应用代表了市场中的一个新兴领域，利用日益增长的糖尿病患者群体和对更便捷检测解决方案的需求。实时数据访问和与数字健康平台的集成等创新功能正在重塑这一细分市场，使其对消费者和医疗提供者越来越具吸引力。虽然血液检测专注于广泛的临床应用，但葡萄糖检测则通过其以患者为中心的方法和技术进步不断突破界限。

### 按技术：振动技术（最大）与喷射注射技术（增长最快）

无针采血装置市场展示了多样化的技术，其中振动技术作为主导力量，占据了最大的市场份额。这项技术有效利用快速振动来促进无针采血，使其成为各种医疗环境中的首选。

相反，喷射注射技术作为增长最快的细分市场正在获得关注，利用高压喷射进行采血。对无痛程序的日益需求，加上该技术的进步，推动了其增长。随着医疗提供者越来越重视患者舒适度，无针装置的采用预计将上升，进一步增强该细分市场的竞争动态。

技术：振动技术（主导）与喷射注射技术（新兴）

振动技术在无针采血设备市场中脱颖而出，因其在效率和患者舒适度方面的良好声誉。这项技术能够在最大限度减少疼痛的同时，确保成功采血，使其成为医疗提供者的主导选择。相比之下，喷射注射技术被视为一个新兴参与者，以其创新的采血方法而闻名。随着其逐渐普及，它承诺通过提供快速无痛的替代方案来提升整体患者体验。这两种技术反映了采血实践向更以患者为中心的方向的重大转变，突显了市场向安全和舒适演变的趋势。

### 按最终用途：医院（最大）与居家护理环境（增长最快）

在无针采血设备市场中，医院目前主导着终端使用细分市场，占据了最大的份额，这得益于其庞大的患者群体和对创新技术日益增长的采用。诊所和实验室也有显著贡献，但它们的份额相对较小。家庭护理环境也正在成为一个关键参与者，受到对居家医疗解决方案和患者舒适度日益偏好的推动，鼓励在这一领域进行重大投资。

医院（主导）与居家护理环境（新兴）

医院是无针血液采集设备的主要终端使用领域，因为它们优先考虑高效和安全的患者护理实践。这些设备的整合旨在减少针刺伤的风险，并提高患者在血液采集过程中的舒适度。另一方面，家庭护理环境被视为一个新兴领域，反映了医疗趋势向以患者为中心的转变。无针血液采集设备在家庭环境中的便利性和有效性满足了对家庭诊断日益增长的需求，从而使其成为个性化医疗中不可或缺的工具。

### 按分销渠道：在线零售（最大）与直接销售（增长最快）

在无针采血设备市场中，分销渠道展示了消费者和医疗提供者多样化的选择。在线零售已成为最大的渠道，因其提供的便利性和可及性而吸引了广泛的受众。药店和医疗分销商也占有重要份额，为医疗机构和患者提供必要的分销点，尽管与在线销售相比，它们在整体市场份额上仍然落后。
增长趋势动态，尤其是直接销售，目前被认为是该市场增长最快的分销渠道。这一增长得益于对直接接触供应商的日益偏好，促进了医疗机构更快的采购流程。此外，远程医疗服务的兴起增强了在线零售的效率，使患者能够在没有传统障碍的情况下获取无针设备，进一步推动了市场扩展。

在线零售（主导）与直接销售（新兴）

在线零售已成为无针采血设备分销的主导力量，利用在线购物的便利性和医疗保健电子商务的增长趋势。它既服务于个人消费者，也服务于医疗机构，提供广泛的选择和送货上门的便利。相比之下，直接销售代表了一种新兴渠道，在偏好与制造商直接接触的医疗服务提供者中获得了关注。这种方法允许个性化服务，并可能提供更好的定价结构，使其在一个关注降低成本和改善获取创新医疗解决方案的市场中具有吸引力。

## Regional Market Share Analysis

无针采血装置市场在各个地区正经历显著增长，2023年的估值为21.2亿美元。北美市场领先，2023年估值为9.5亿美元，预计到2032年将达到20.5亿美元，反映出其在创新和医疗基础设施中的重要作用。

欧洲紧随其后，2023年估值为7.5亿美元，预计到2032年将增长至15.5亿美元，这主要得益于医疗技术的进步和对微创手术日益增长的需求。亚太地区显示出增长潜力，2023年起步于3亿美元，预计到2032年将上升至8亿美元，随着医疗投资的增加和患者人数的上升。

南美和中东非洲的市场份额较小，2023年分别估值为5000万美元和7000万美元，但预计到2032年将增长至1500万美元和2500万美元，突显出随着这些地区医疗服务的改善而带来的扩展机会。总体而言，多样化的无针采血装置市场细分呈现出多种增长驱动因素、挑战和机会，强调了其在医疗行业中的潜力。

来源：初步研究，二次研究，_市场研究未来_数据库和分析师评审

## Competitive Benchmarking

无针采血装置市场正在迅速发展，推动这一市场的是对更安全、更高效的采血方法日益增长的需求。由于其提升患者舒适度、降低针刺伤害风险和减少生物危害废物的潜力，该市场引起了相当大的关注。该细分市场的竞争动态突显了各种参与者的创新和产品组合扩展，强调技术进步以满足多样化的医疗需求。

随着全球医疗系统向更以患者为中心的解决方案转变，竞争格局由一系列成熟制造商和新兴初创企业构成，这些企业寻求在无针技术中开辟自己的市场。除了创新，市场参与者还专注于合作伙伴关系和协作，旨在增强市场覆盖率和提升技术能力，最终塑造采血过程的未来格局。费森尤斯·卡比在无针采血装置市场中有效地定位自己，强调高质量医疗解决方案。

该公司在医疗和制药领域展现出广泛的专业知识，建立了创新和可靠性的声誉。费森尤斯·卡比在这一细分市场的优势包括其对研发的承诺，使公司能够提供符合监管标准并满足伦理供应链要求的先进无针采血产品。此外，费森尤斯·卡比庞大的分销网络确保其创新设备的广泛可及性，进一步巩固了其竞争优势。

通过关注患者安全和舒适，该公司与医疗提供者和患者日益变化的偏好保持一致，从而巩固了其在这一增长市场中的地位。另一方面，南特生物在无针采血装置市场中展现出引人注目的运营概述，强调产品有效性和用户体验。南特生物采用创新的方法进行采血技术的开发，结合了先进的科学与实际应用。该公司利用复杂的研究方法设计出在采血过程中最小化不适感的设备，最终提升患者满意度。

南特生物还与多个医疗系统建立了战略联盟，促进其无针解决方案的采用，并与减少医疗环境中侵入性程序的日益趋势保持一致。其在响应市场需求和要求方面的灵活性使南特生物能够迅速适应和创新，从而增强其在这一竞争激烈、技术快速进步和消费者偏好不断变化的行业中的存在感。

## Recent News & Developments

无针采血装置市场最近经历了显著的发展，特别是在技术进步和消费者对无痛程序需求增加的背景下。多家公司，如费森尤斯·卡比、法玛捷和贝克顿·迪金森，推出了创新设备，以提升用户体验并减少不适感。市场正在经历投资激增，像齐佳科技和维塔针头这样的公司在研发方面取得了进展，以推出更高效的无针系统。目前的趋势表明，市场正向家庭医疗解决方案转变，符合患者对便利性和安全性日益增长的偏好。

 此外，关键的并购活动正在塑造市场格局，像泰尔茂和瓦莱瑞塔这样的公司正在探索战略合作伙伴关系，以扩展其产品供应。这些公司的估值正在上升，反映出由技术进步和日益关注以患者为中心的解决方案推动的市场潜力。随着行业的发展，像血流静止和微针技术这样的公司也在寻求合作，以增强其市场覆盖率和客户参与度。这一动态变化的环境突显了无针采血装置市场内更广泛的转型。

## Report Scope

| 2024年市场规模 | 2514（亿美元） |
| --- | --- |
| 2025年市场规模 | 2741（亿美元） |
| 2035年市场规模 | 65（亿美元） |
| 复合年增长率（CAGR） | 9.02%（2024 - 2035） |
| 报告覆盖范围 | 收入预测、竞争格局、增长因素和趋势 |
| 基准年 | 2024 |
| 市场预测期 | 2025 - 2035 |
| 历史数据 | 2019 - 2024 |
| 市场预测单位 | 亿美元 |
| 主要公司简介 | 市场分析进行中 |
| 覆盖的细分市场 | 市场细分分析进行中 |
| 主要市场机会 | 技术进步和对患者舒适度的需求增加推动无针采血设备市场的增长。 |
| 主要市场动态 | 技术进步和监管支持推动无针采血设备在医疗环境中的采用。 |
| 覆盖的国家 | 北美、欧洲、亚太、南美、中东和非洲 |

## Frequently Asked Questions

**Q: 2035年无针采血设备市场的预计市场估值是多少？**
A: 预计到2035年，无针采血设备市场的市场估值为65亿美元。

**Q: 2024年无针采血设备市场的市场估值是多少？**
A: 2024年无针采血设备市场的市场估值为25.14亿美元。

**Q: 2025年至2035年无针血液采集设备市场的预期CAGR是多少？**
A: 在2025年至2035年的预测期内，无针血液采集设备市场的预期CAGR为9.02%。

**Q: 在无针血液采集设备市场中，预计哪个技术细分领域的估值最高？**
A: 喷射注射技术部门预计到2035年将达到32.5亿美元的估值。

**Q: 2024年和2035年之间，血液检测细分估值的比较如何？**
A: 血液检测细分市场的估值预计将从2024年的7.54亿美元增长到2035年的19.5亿美元。

**Q: 无针采血设备市场的关键参与者有哪些？**
A: 市场上的主要参与者包括GlucoRx、VivaLNK、Becton Dickinson、HemoCue、Nemaura Medical、Tasso Inc.、Syris Scientific和Aterica。

**Q: 到2035年，预计哪个最终用途细分市场将显示出显著增长？**
A: 医院终端使用细分市场预计将从2024年的9亿美元增长到2035年的23亿美元。

**Q: 无针采血设备市场中家庭护理环境细分市场的预期增长是多少？**
A: 预计家庭护理设置细分市场将从2024年的5亿美元增长到2035年的12亿美元。

**Q: 药店的分销渠道与在线零售在市场估值方面有何比较？**
A: 预计到2035年，药店的市场规模将从2024年的8亿美元增长到20亿美元，超过预计将达到13亿美元的在线零售市场。


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/needle-free-blood-drawing-device-market-38906*